Cleared Special

K063476 - BREAS ISLEEP 20I

K063476 is an FDA 510(k) clearance for BREAS ISLEEP 20I, manufactured by Breas Medical AB. The device is a Class 2 Anesthesiology device with product code BZD cleared through the Special 510(k) pathway after a 67-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2007
Decision
67d
Days
Class 2
Risk

K063476 is an FDA 510(k) clearance for the BREAS ISLEEP 20I. Classified as Ventilator, Non-continuous (respirator) (product code BZD), Class II - Special Controls.

Submitted by Breas Medical AB (Molnlycke, SE). The FDA issued a Cleared decision on January 22, 2007 after a review of 67 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5905 - the FDA anesthesiology and respiratory device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Breas Medical AB devices

FDA 510(k) Submission Details - K063476

510(k) Number K063476 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 16, 2006
Decision Date January 22, 2007
Days to Decision 67 days
Submission Type Special
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
73d faster than avg
Panel avg: 140d · This submission: 67d
Pathway characteristics
Modification to existing cleared device.

BZD Device Classification - Class 2, Special Controls

Product Code BZD Ventilator, Non-continuous (respirator)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5905
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BZD Ventilator, Non-continuous (respirator)

All 286
Devices cleared under the same product code (BZD) and FDA review panel - the closest regulatory comparables to K063476.
TWILIGHT FULL FACE MASK
K070321 · Invacare Corp. · Apr 2007
MIRAGE LIBERTY FULL FACE MASK
K063011 · Resmed, Ltd. · Feb 2007
MIRAGE QUATTRO FULL FACE MASK
K063122 · Resmed, Ltd. · Feb 2007
OPUS HC482 DIRECT NASAL MASK
K063036 · Fisher &Paykel Healthcare , Ltd. · Dec 2006
VPAP MALIBU WITH H2I
K062291 · Resmed, Ltd. · Sep 2006
INVACARE'S TWILIGHT II NASAL MASKS
K061874 · Invacare Corp. · Sep 2006